Authors: Poxviridae

Colin McInnes*
Chair, Poxviridae Study Group
Moredun Research Institute
Edinburgh
UK
E-mail: colin.mcinnes@moredun.ac.uk

Inger Damon
Poxvirus and Rabies Branch
Centers for Disease Control and Prevention
Atlanta
Georgia 30333
USA
E-mail: iad7@cdc.gov

Geoffrey Smith
Sir William Dunn School of Pathology,
University of Oxford,
South Parks Road,
Oxford, OX1 3RE
UK
E-mail: geoffrey.smith@path.ox.ac.uk

Grant McFadden
Biodesign Center for Immunotherapy Vaccines and Virotherapy
Arizona State University
Tempe
Arizona 85287
USA
E-mail: grantmcf@asu.edu

Stuart Isaacs
Division of Infectious Diseases
Perelman School of Medicine
University of Pennsylvania
Philadelphia
USA
E-mail: isaacs@pennmedicine.upenn.edu

Rachel Roper
Department of Microbiology and Immunology
Brody School of Medicine
East Carolina University
Greenville
North Carolina 27834
USA
E-mail: roperr@ecu.edu

David Evans
Department of Medical Microbiology & Immunology
and Li Ka Shing Institute of Virology
University of Alberta
Edmonton
Alberta T6G 2J7
Canada
E-mail: devans@ualberta.ca

Clarissa Damaso
Instituto de Biofísica Carlos Chagas Filho
Cidade Universitária da Universidade Federal do Rio de Janeiro
Rio de Janeiro
RJ, 21941-902
Brazil
E-mail: damasoc@biof.ufrj.br

Olivia Carulei
Division of Medical Virology
Faculty of Health Scienc
University of Capetown
Capetown 7925
South Africa
E-mail: ocarulei@gmail.com

Lyn Wise
Department of Pharmacology and Toxicology
School of Biomedical Sciences,
University of Otago
Dunedin 9054
New Zealand
E-mail: lyn.wise@otago.ac.nz

Elliot Lefkowitz
Department of Microbiology
UAB School of Medicine
University of Alabama at Birmingham
Birmingham
Alabama 35294
USA
E-mail: elliotl@uab.edu

* To whom correspondence should be addressed
The chapter in the Ninth ICTV Report, which served as the template for this chapter, was contributed by Skinner, M.A., Buller, R.M., Damon, I.K., Lefkowitz, E.J., McFadden, G., McInnes, C.J., Mercer, A.A., Moyer, R.W. and Upton, C.